Vivet Therapeutics Investors

19 investors on Angel Roster list Vivet Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in Spain, France and the United States.

Investors are matched on the company name in their portfolio, so companies that share the name Vivet Therapeutics can appear together.

Investors listed
19
With verified email
37%
Most common stage
Seed
Top location
Spain

Updated October 13, 2026 · How we compile this data

Top 19 Vivet Therapeutics investors

The most complete profiles first. Showing 19 of 19.

  • Chris JacksonVerified

    Venture Capital, Investor · United States

    SeedHealth CareE-commerceWomen FoundedLife Science

    Portfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more

    Verified email available

  • Cristina GarmendiaVerified

    Venture Capital · Spain

    SeedPre-SeedHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: TiGenix, AM Pharma, Ona Therapeutics, STAT-Dx and 27 more

    Verified email available

  • Philippe PeltierVerified

    Venture Capital, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: Implanet, AM Pharma, FeetMe, Advanced Perfusion Diagnostics and 36 more

    Verified email available

  • Thierry LaugelVerified

    Venture Capital, Private Equity Firm, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Verified email available

  • Vanessa MalierVerified

    Venture Capital, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Verified email available

  • Jason DoddVerified

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceSoftware

    Portfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more

    Contact details available

  • Keith UnderwoodVerified

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceSoftware

    Portfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more

    Verified email available

  • Amine MAROUF

    Venture Capital, Private Equity Firm, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Hadrien Bouchez

    Venture Capital, Private Equity Firm, Investor · Netherlands

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Per Samuelsson

    Venture Capital, Private Equity Firm, Investor · Sweden

    SeedHealth CareWomen FoundedLife ScienceSoftware

    Portfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more

    Contact details available

  • Staffan Lindstrand

    Venture Capital, Private Equity Firm, Investor · Sweden

    SeedHealth CareWomen FoundedLife ScienceSoftware

    Portfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more

    Contact details available

  • Sylvain Cascarino

    Venture Capital, Private Equity Firm, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Guillem Laporta, CFA

    Venture Capital, Private Equity Firm · Spain

    Health CareWomen FoundedLife ScienceManufacturing

    Portfolio: TiGenix, AM Pharma, Ona Therapeutics, STAT-Dx and 27 more

    Contact details available

  • Iñigo López

    Venture Capital, Private Equity Firm · Spain

    Health CareWomen FoundedLife ScienceManufacturing

    Portfolio: TiGenix, AM Pharma, Ona Therapeutics, STAT-Dx and 27 more

    Contact details available

  • Jessica Vitos

    Venture Capital · Spain

    Health CareWomen FoundedLife ScienceManufacturing

    Portfolio: TiGenix, AM Pharma, Ona Therapeutics, STAT-Dx and 27 more

    Contact details available

  • Jordi Xiol

    Venture Capital, Private Equity Firm · Spain

    Health CareWomen FoundedLife ScienceManufacturing

    Portfolio: TiGenix, AM Pharma, Ona Therapeutics, STAT-Dx and 27 more

    Contact details available

  • Nikki Matthews

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceSoftware

    Portfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more

    Contact details available

  • Peter Neubeck

    Venture Capital, Private Equity Firm · Germany

    Health CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Javier GarciaVerified

    Venture Capital · Spain

    Health CareHospitalsWomen FoundedInvestment Management

    Portfolio: SANIFIT, Aura Biosciences, Highlight Therapeutics, Artax Biopharma and 1 more

    Verified email available

Frequently asked questions

How many Vivet Therapeutics investors are on Angel Roster?

Angel Roster lists 19 Vivet Therapeutics investors. 7 of them (37%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (19) and Private Equity Firms (10). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Vivet Therapeutics investors invest in?

Among those that list a stage, the most common are Seed (10) and Pre-Seed (1).

Where are Vivet Therapeutics investors based?

Most are based in Spain (6), France (5) and the United States (4).

Which companies have Vivet Therapeutics investors backed?

The most-backed portfolio companies among them are OxThera (18), STAT-Dx (12), AM Pharma (12), Medlumics (12) and Xeltis (12).

How do I contact Vivet Therapeutics investors?

Create a free Angel Roster account to search and filter all 19, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.